Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder

NCT ID: NCT03806946

Last Updated: 2020-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-15

Study Completion Date

2020-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The most common neuropsychiatric disorder in early childhood is attention deficit/hyperactivity disorder (ADHD) with evidence of abnormality in structure and function of brain. Epilepsy is one of the commonest comorbidity associated with ADHD with negative outcome on childrens' quality of life, and is considered to be a risk for academic underachievement. These two disorders are highly associated, with more possibility to be a bidirectional relationship. The mechanisms of this comorbidity are unknown. In this association, a difficult challenge is presented since antiepileptic therapy and drugs used to treat ADHD may aggravate the clinical picture of each other. The main objectives are to evaluate this overlap of those disorders, find their complications on child and his family, and to suggest possible solutions to improve the outcome of those children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The commonest childhood disorder is attention deficit hyperactivity disorder(ADHD) which continues into adulthood.The main two symptoms are inattention and hyperactivity.

As epilepsy is one of the commonest comorbidity with ADHD to about (40%), there are many overlap symptoms between both disorders for example:

* Behavioral features which are shared in both frontal lobe epilepsy with ADHD such as impulsivity, disinhibition, and irritability
* The electroencephalogram: there is an increase in the rate of spikes in children with ADHD with no epileptic symptoms, which supports the theory of presence similar mechanism about central nervous system dysfunction.

These reasons lead to increase obstacles for diagnosis, assessment, and treatment for both disorders.

As this comorbidity duplicates the complications (i.e. drop the school, financial cost, stress on families, negative effect on academic, vocational, social relations and self-esteem ) so there is a great need to study this comorbidity to give a proper care for these patients.

In this study, all participants will be enrolled over a period of 12 months from Assiut outpatients clinic .All participants will be assessed in the psychiatric interview by using prepared child and adolescent psychiatric sheet include (psychiatric and neurology history, physical examination and mental state examination). After that electroencephalogram(EEG) will be done to diagnoses epilepsy and identify different types of seizures.

All participants will be categorizing into 4 groups ( ADHD, epilepsy, ADHD,and epilepsy, healthy) according to EEG and the psychiatric sheet. Each group will be assessed by different psychometrics scales to evaluate cognitive, social, economic and behavioral outcome. The results of all groups will be analysed by using Stata version 15 to evaluate the effect of ADHD and epilepsy in children and adolescent and identify the possible risk factors to improve outcome

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention-Deficit Hyperactivity Disorder Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group1

ADHD with normal EEG

electroencephalography

Intervention Type DIAGNOSTIC_TEST

diagnosis epileptic discharge

psychometric scales to diagnosis psychiatric disorders

Intervention Type DIAGNOSTIC_TEST

to diagnosis intellectual disability, attention deficit hyperactivity disorder ,epilepsy,autism and other mental illness.

psychometric scales for assesment socioeconomic and behaviour problems

Intervention Type OTHER

to assessment other behavioural comorbidity as aggression ,mood changes,etc and help in identify function impairment, social and economic burden

group 2

ADHD with abnormal EEG

electroencephalography

Intervention Type DIAGNOSTIC_TEST

diagnosis epileptic discharge

psychometric scales to diagnosis psychiatric disorders

Intervention Type DIAGNOSTIC_TEST

to diagnosis intellectual disability, attention deficit hyperactivity disorder ,epilepsy,autism and other mental illness.

psychometric scales for assesment socioeconomic and behaviour problems

Intervention Type OTHER

to assessment other behavioural comorbidity as aggression ,mood changes,etc and help in identify function impairment, social and economic burden

group 3

Epilepsy

electroencephalography

Intervention Type DIAGNOSTIC_TEST

diagnosis epileptic discharge

psychometric scales to diagnosis psychiatric disorders

Intervention Type DIAGNOSTIC_TEST

to diagnosis intellectual disability, attention deficit hyperactivity disorder ,epilepsy,autism and other mental illness.

psychometric scales for assesment socioeconomic and behaviour problems

Intervention Type OTHER

to assessment other behavioural comorbidity as aggression ,mood changes,etc and help in identify function impairment, social and economic burden

group 4

Healthy control group

electroencephalography

Intervention Type DIAGNOSTIC_TEST

diagnosis epileptic discharge

psychometric scales to diagnosis psychiatric disorders

Intervention Type DIAGNOSTIC_TEST

to diagnosis intellectual disability, attention deficit hyperactivity disorder ,epilepsy,autism and other mental illness.

psychometric scales for assesment socioeconomic and behaviour problems

Intervention Type OTHER

to assessment other behavioural comorbidity as aggression ,mood changes,etc and help in identify function impairment, social and economic burden

group 5

ADHD and epilepsy

electroencephalography

Intervention Type DIAGNOSTIC_TEST

diagnosis epileptic discharge

psychometric scales to diagnosis psychiatric disorders

Intervention Type DIAGNOSTIC_TEST

to diagnosis intellectual disability, attention deficit hyperactivity disorder ,epilepsy,autism and other mental illness.

psychometric scales for assesment socioeconomic and behaviour problems

Intervention Type OTHER

to assessment other behavioural comorbidity as aggression ,mood changes,etc and help in identify function impairment, social and economic burden

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electroencephalography

diagnosis epileptic discharge

Intervention Type DIAGNOSTIC_TEST

psychometric scales to diagnosis psychiatric disorders

to diagnosis intellectual disability, attention deficit hyperactivity disorder ,epilepsy,autism and other mental illness.

Intervention Type DIAGNOSTIC_TEST

psychometric scales for assesment socioeconomic and behaviour problems

to assessment other behavioural comorbidity as aggression ,mood changes,etc and help in identify function impairment, social and economic burden

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

EEG WISC III (Wechsler Intelligence Scale for Children),conners 3rd Edition,(cbcl)The Child Behavior Checklis,Epilepsy interview,The Childhood Autism Spectrum Test (CAST) socioeconomic class, pediatric quality of life inventory, The Strengths and Difficulties Questionnaire (SDQ),The Mood and Feelings Questionnaire (MFQ),

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both males and females were included.
* Age range from 6- 11 years.
* Diagnosis of ADHD and/or epilepsy was verified and confirmed either on a clinical basis or by using reliable psychometric tests.
* In epilepsy groups: only Idiopathic type was included.
* Willing of the parents or the caregivers to participate in the study.

Exclusion Criteria

* Children whom caretakers refused to give informed consent.
* Children with intelligence quotient below 70.
* Children with history or current substance use.
* Children with medical or other neurological conditions.
Minimum Eligible Age

6 Years

Maximum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gellan Karamalllah Ramadan Ahmed

Assistent lecture

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alaa El-Din Darweesh, PhD

Role: STUDY_DIRECTOR

Assiut University

HossamEddin Ahmad, PhD

Role: STUDY_CHAIR

Assiut University

Patrick Bolton, PhD

Role: STUDY_CHAIR

King's College London

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut University Hospital

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Dunn DW, Austin JK, Huster GA. Behaviour problems in children with new-onset epilepsy. Seizure. 1997 Aug;6(4):283-7.

Reference Type RESULT
PMID: 9304719 (View on PubMed)

Kanner AM. The use of psychotropic drugs in epilepsy: what every neurologist should know. Semin Neurol. 2008 Jul;28(3):379-88. doi: 10.1055/s-2008-1079342. Epub 2008 Jul 24.

Reference Type RESULT
PMID: 18777484 (View on PubMed)

Chou IC, Chang YT, Chin ZN, Muo CH, Sung FC, Kuo HT, Tsai CH, Kao CH. Correlation between epilepsy and attention deficit hyperactivity disorder: a population-based cohort study. PLoS One. 2013;8(3):e57926. doi: 10.1371/journal.pone.0057926. Epub 2013 Mar 6.

Reference Type RESULT
PMID: 23483944 (View on PubMed)

Sherman EM, Slick DJ, Connolly MB, Eyrl KL. ADHD, neurological correlates and health-related quality of life in severe pediatric epilepsy. Epilepsia. 2007 Jun;48(6):1083-91. doi: 10.1111/j.1528-1167.2007.01028.x. Epub 2007 Mar 22.

Reference Type RESULT
PMID: 17381442 (View on PubMed)

Kaufmann R, Goldberg-Stern H, Shuper A. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. J Child Neurol. 2009 Jun;24(6):727-33. doi: 10.1177/0883073808330165.

Reference Type RESULT
PMID: 19491115 (View on PubMed)

Kirov R, Kinkelbur J, Banaschewski T, Rothenberger A. Sleep patterns in children with attention-deficit/hyperactivity disorder, tic disorder, and comorbidity. J Child Psychol Psychiatry. 2007 Jun;48(6):561-70. doi: 10.1111/j.1469-7610.2007.01729.x.

Reference Type RESULT
PMID: 17537072 (View on PubMed)

Dickstein, L.J., Roba, M.B. and Oldham, J.M.(1997): Review of psychiatry. AmericanPsychiatric Press. Washington, DC. London,England.

Reference Type RESULT

Ahmed GK, Darwish AM, Khalifa H, Khashbah MA. Evaluation of psychiatric comorbidity in attention-deficit hyperactivity disorder with epilepsy: A case-control study. Epilepsy Res. 2021 Jan;169:106505. doi: 10.1016/j.eplepsyres.2020.106505. Epub 2020 Nov 21.

Reference Type DERIVED
PMID: 33302225 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Impact of ADHD and epilepsy

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.